5 Chinese pharma companies sign on to make generic version of Pfizer's oral COVID pill - Global Times

Five pharmaceutical companies in China have signed on with UN-backed public health organization Medicines Patent Pool (MPP) to manufacture the generic version of Pfizer's oral COVID-19 treatment, nirmatrelvir, for supply in 95 low- and middle-income countries…

Five pharmaceutical companies in China have signed on with UN-backed public health organization Medicines Patent Pool (MPP) to manufacture the generic version of Pfizer's oral COVID-19 treatment, nir… [+1938 chars]

full article...